MEGAN DAVISON: Open Payments
NPI 1740988518 · CAYCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 54 payments from 13 companies in 2025. Trend: 2023 $614 · 2024 $1,162 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $162 |
| ABBVIE INC. | 12 | $160 |
| AstraZeneca Pharmaceuticals LP | 5 | $137 |
| PFIZER INC. | 6 | $133 |
| Exact Sciences Corporation | 5 | $86 |
| Amgen Inc. | 4 | $63 |
| Lilly USA, LLC | 4 | $59 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Edwards Lifesciences Corporation | 1 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: NURTEC ODT, AIRSUPRA, Ozempic, Cologuard Collection Kit, QULIPTA, MOUNJARO, Wegovy, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
